Publicação: Esparfloxacino e as fluorquinolonas: Uma revisao de sua classificacao, atividade antibacteriana, mecanismo de acao, caracteristicas farmacocineticas, tolerabilidade e perspectivas farmaceuticas
dc.contributor.author | Marona, H. R N [UNESP] | |
dc.contributor.author | Schapoval, E. E S [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2014-05-27T11:19:51Z | |
dc.date.available | 2014-05-27T11:19:51Z | |
dc.date.issued | 1999-12-01 | |
dc.description.abstract | A revision was accomplished in the literature on the quinolones, antibacterial class that presents wide action spectrum, focusing, mainly, the sparfloxacin, third generation fluorquinolone which has potente activity against Gram positive organisms, including Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA), Gram negative organisms, Legionelia spp, Mycoplasma spp, Chlamydia spp and Mycobacterium spp, including multidrug resistant organisms. | en |
dc.description.affiliation | Depto. de Farmacos e Medicamentos Faculdade de Ciencias Farmaceuticas UNESP, Araraquara, SP | |
dc.description.affiliationUnesp | Depto. de Farmacos e Medicamentos Faculdade de Ciencias Farmaceuticas UNESP, Araraquara, SP | |
dc.format.extent | 301-333 | |
dc.identifier.citation | Revista de Ciencias Farmaceuticas, v. 20, n. 2, p. 301-333, 1999. | |
dc.identifier.issn | 0101-3793 | |
dc.identifier.scopus | 2-s2.0-0033302426 | |
dc.identifier.uri | http://hdl.handle.net/11449/66016 | |
dc.language.iso | por | |
dc.relation.ispartof | Revista de Ciencias Farmaceuticas | |
dc.rights.accessRights | Acesso restrito | pt |
dc.source | Scopus | |
dc.subject | Antibacterial activity | |
dc.subject | Fluoroquinolones | |
dc.subject | Quinolones | |
dc.subject | Sparfloxacin | |
dc.subject | antiinfective agent | |
dc.subject | ciprofloxacin | |
dc.subject | fleroxacin | |
dc.subject | irloxacin | |
dc.subject | levofloxacin | |
dc.subject | lomefloxacin | |
dc.subject | nadifloxacin | |
dc.subject | nalidixic acid | |
dc.subject | norfloxacin | |
dc.subject | ofloxacin | |
dc.subject | pefloxacin | |
dc.subject | pefloxacin mesilate | |
dc.subject | pipemidic acid | |
dc.subject | quinoline derived antiinfective agent | |
dc.subject | quinolone derivative | |
dc.subject | rufloxacin | |
dc.subject | sparfloxacin | |
dc.subject | trovafloxacin | |
dc.subject | antibacterial activity | |
dc.subject | drug distribution | |
dc.subject | drug mechanism | |
dc.subject | drug structure | |
dc.subject | drug tolerability | |
dc.subject | flatulence | |
dc.subject | gastrointestinal symptom | |
dc.subject | Gram positive bacterium | |
dc.subject | human | |
dc.subject | nonhuman | |
dc.subject | review | |
dc.subject | structure activity relation | |
dc.title | Esparfloxacino e as fluorquinolonas: Uma revisao de sua classificacao, atividade antibacteriana, mecanismo de acao, caracteristicas farmacocineticas, tolerabilidade e perspectivas farmaceuticas | pt |
dc.title.alternative | Sparfloxacin and the flouroquinolones: A review of classification, antibacterial activity, mechanism of action, pharmacokinetic properties, tolerability and pharmaceutical perspective | en |
dc.type | Resenha | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
relation.isDepartmentOfPublication.latestForDiscovery | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
relation.isOrgUnitOfPublication | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
relation.isOrgUnitOfPublication.latestForDiscovery | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquara | pt |
unesp.department | Fármacos e Medicamentos - FCF | pt |